𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Critical role of CD23 in allergen-induced bronchoconstriction in a murine model of allergic asthma

✍ Scribed by Gorana Dasic; Pierre Juillard; Pierre Graber; Suzanne Herren; Tony Angell; Richard Knowles; Jean-Yves Bonnefoy; Marie H. Kosco-Vilbois; Yolande Chvatchko


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
408 KB
Volume
29
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


CD23-deficient and anti-CD23 monoclonal antibody-treated mice were used to investigate the role of the low-affinity receptor for IgE (CD23) in allergic airway inflammation and airway hyperresponsiveness (AHR). While there were no significant differences in ovalbumin (OVA)specific IgE titers and tissue eosinophilia, evaluation of lung function demonstrated that CD23 -/-mice showed an increased AHR to methacholine (MCh) when compared to wildtype mice but were completely resistant to the OVA challenge. Anti-CD23 Fab fragment treatment of wild-type mice did not affect the MCh-induced AHR but significantly reduced the OVA-induced airway constriction. These results imply a novel role for CD23 in lung inflammation and suggest that anti-CD23 Fab fragment treatment may be of therapeutic use in allergic asthma.


📜 SIMILAR VOLUMES


Definitive engagement of cytotoxic CD8 T
✍ Takahiko Sugihara; Naoko Okiyama; Mihoko Suzuki; Kuniko Kohyama; Yoh Matsumoto; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

## Abstract ## Objective To substantiate a pathogenic role of cytotoxic CD8 T cells in the development of a murine polymyositis model, C protein–induced myositis (CIM). ## Methods Beta~2~‐microglobulin–null mutant, perforin‐null mutant, and wild‐type (WT) C57BL/6 mice were immunized with skeleta

IL-12- and IL-2-induced tumor regression
✍ Giovana R. Thomas; Zhong Chen; Ileana Enamorado; Caren Bancroft; Carter Van Waes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 2 views

Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu